HR Pharmaceuticals, Inc. Received Exclusive Commercialization Rights to Poiesis Medical’s Dual Balloon Catheter Technology in North America
On December 28, 2023, HR Pharmaceuticals entered into a collaboration with Poiesis Medical LLC, to license Poiesis's Dual Balloon Catheter (Duette™). According to the terms of the agreement, HR Pharmaceuticals will exercise exclusive commercialization rights in North America. The product broadens HR Pharmaceuticals expanding urological portfolio across the continuum of treatment. The DuetteTM has a unique design to manage adverse events associated with Foley Catheterization, which is particularly significant for certain pa...